#CPV

Parvo preventative picks up speed

December 29, 2020

Elanco Animal Health is set to acquire the global rights to Kindred Biosciences’ proprietary KIND-030, a monoclonal antibody being developed for the treatment and prevention of canine parvovirus.

The ripple effect of heartworm disease on your mental health

As a veterinarian, you feel every emotional ripple of heartworm disease. The pain and suffering of your canine patient. The anguish and concern of your client. And of course, the responsibility and emotional drain as you treat the disease.

+ Learn More

Preventative for deadly puppy disease may be imminent

September 18, 2020

An efficacy study of a monoclonal antibody targeting canine parvovirus has shown complete efficacy in its prevention, its maker says.

Canine parvovirus treatment may be in the works

August 19, 2019

Veterinarians may soon have access to an antibody effective in the treatment of canine parvovirus (CPV).

New on

Join VPN Plus+ today to get access to exclusive content like:

Compassion without the fatigue

Video: Tips to working with clients who have mental health conditions

We finally learn…what’s in the box!

A new way to go green: mentor a recent graduate

Join Now!

COVID-19

Virtual care claims jumped 379 percent during pandemic

Pets unlikely to pass COVID-19 to humans, other animals

How are you and your team doing?

Making technology work while in coronavirus mode (and beyond)

Report animal drug shortages ASAP

About Us
About VPN Plus+
Contact Us
Advertise

Get the Magazine
Get our Newsletter

FOLLOW US @VetPracticeNews
#VetPracticeNews